BACK TO INDEX

Publications of A. Prigent
Articles in journal or book chapters
  1. V. Brochard, B. Combadiere, A. Prigent, Y. Laouar, A. Perrin, V. Beray-Berthat, O. Bonduelle, D. Alvarez-Fischer, J. Callebert, J. M. Launay, C. Duyckaerts, R. A. Flavell, E. C. Hirsch, and S. Hunot. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest, 119(1):182-92, 2009. Note: Howard Hughes Medical Institute/United StatesJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW]


  2. J. Salazar, N. Mena, S. Hunot, A. Prigent, D. Alvarez-Fischer, M. Arredondo, C. Duyckaerts, V. Sazdovitch, L. Zhao, L. M. Garrick, M. T. Nunez, M. D. Garrick, R. Raisman-Vozari, and E. C. Hirsch. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci U S A, 105(47):18578-83, 2008. Note: Journal ArticleUnited States. [WWW]


  3. M. Namekawa, M. P. Muriel, A. Janer, M. Latouche, A. Dauphin, T. Debeir, E. Martin, C. Duyckaerts, A. Prigent, C. Depienne, A. Sittler, A. Brice, and M. Ruberg. Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis. Mol Cell Neurosci, 35(1):1-13, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Cell Line, Cytoplasmic Vesicles/*enzymology/ultrastructure, Endoplasmic Reticulum/*enzymology/ultrastructure, Epitopes, GTP Phosphohydrolases/*genetics/*metabolism, Golgi Apparatus/*enzymology/ultrastructure, Humans, Kidney/cytology, Microscopy, Electron, Motor Cortex/cytology, Motor Neurons/*enzymology, Paraplegia/genetics/metabolism, Point Mutation, Protein Transport/physiology, Spinal Cord/cytology.


  4. G. U. Hoglinger, A. Lannuzel, M. E. Khondiker, P. P. Michel, C. Duyckaerts, J. Feger, P. Champy, A. Prigent, F. Medja, A. Lombes, W. H. Oertel, M. Ruberg, and E. C. Hirsch. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem, 95(4):930-9, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Amyloid beta-Protein/metabolism, Analysis of Variance, Animals, Antineoplastic Combined Chemotherapy Protocols/metabolism, Behavior, Animal, Body Weight/drug effects, Caspase 3, Caspases/metabolism, Cell Death/drug effects, Cerebral Cortex/*drug effects/pathology/physiopathology, Cytarabine/metabolism, Diagnostic Imaging/methods, Dopamine and cAMP-Regulated Phosphoprotein 32/metabolism, Doxorubicin/metabolism, Dystonia/etiology/physiopathology, Electron Transport Complex III/metabolism, Enzyme Activation/drug effects, Glial Fibrillary Acidic Protein/metabolism, Immunohistochemistry/methods, Locomotion/drug effects, Male, Microscopy, Electron, Transmission/methods, Mitochondria/drug effects/ultrastructure, Neurons/drug effects/physiology, Phosphopyruvate Hydratase/metabolism, Phosphorylation, Posture, Psychomotor Performance/drug effects, Rats, Rats, Inbred Lew, Rotenone/*adverse effects, Tauopathies/*chemically induced/pathology/physiopathology, Thiazoles/diagnostic use, Time Factors, Tyrosine/analogs & derivatives/metabolism, Tyrosine 3-Monooxygenase/metabolism, Ubiquitin/metabolism, Uncoupling Agents/*adverse effects, alpha-Synuclein/metabolism, tau Proteins/metabolism.


  5. T. Debeir, M. Marien, J. Ferrario, P. Rizk, A. Prigent, F. Colpaert, and R. Raisman-Vozari. In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration. Exp Neurol, 190(2):384-95, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Acetylcholine/metabolism, Animals, Benzopyrans/*pharmacology, Brain Ischemia/pathology/physiopathology, Enzyme-Linked Immunosorbent Assay, Imidazoles/*pharmacology, Immunohistochemistry, Nerve Degeneration/*drug therapy, Nerve Growth Factor/*drug effects/metabolism, Neurons/*drug effects/metabolism/pathology, Neuroprotective Agents/*pharmacology, Rats, Receptors, Adrenergic, alpha-2/antagonists & inhibitors, Somatosensory Cortex/blood supply/*drug effects/pathology, Up-Regulation.


  6. O. Corti, C. Hampe, H. Koutnikova, F. Darios, S. Jacquier, A. Prigent, J. C. Robinson, L. Pradier, M. Ruberg, M. Mirande, E. Hirsch, T. Rooney, A. Fournier, and A. Brice. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet, 12(12):1427-37, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Adult, Amino Acyl-tRNA Synthetases/*metabolism, Animals, COS Cells, Carrier Proteins/*metabolism, Cell Death/*drug effects, Cercopithecus aethiops, Humans, Inclusion Bodies, Lewy Bodies/metabolism/pathology, Mesencephalon/*metabolism, Mutation, Nerve Degeneration/metabolism/pathology, Neuroblastoma/metabolism/pathology, Parkinson Disease/*genetics/physiopathology, Saccharomyces cerevisiae, Two-Hybrid System Techniques, Ubiquitin/metabolism, Ubiquitin-Protein Ligases/genetics/*metabolism, p38 Mitogen-Activated Protein Kinases.


  7. E. C. Hirsch, G. Hoglinger, E. Rousselet, T. Breidert, K. Parain, J. Feger, M. Ruberg, A. Prigent, C. Cohen-Salmon, and J. M. Launay. Animal models of Parkinson's disease in rodents induced by toxins: an update. J Neural Transm Suppl, (65):89-100, 2003. Note: Journal ArticleReviewAustria. [WWW] Keyword(s): 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, Adrenergic Agents, Animals, Basal Ganglia/drug effects/metabolism, Brain Stem/drug effects/metabolism, *Disease Models, Animal, Dopamine/metabolism, Dopamine Agents, Nerve Degeneration/*chemically induced, Neurons/*drug effects, Oxidopamine, *Parkinson Disease, *Rodentia, Rotenone, Uncoupling Agents.


  8. G. U. Hoglinger, J. Feger, A. Prigent, P. P. Michel, K. Parain, P. Champy, M. Ruberg, W. H. Oertel, and E. C. Hirsch. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem, 84(3):491-502, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Animals, Behavior, Animal/drug effects, Cell Count, Choline O-Acetyltransferase/biosynthesis, Chronic Disease, Corpus Striatum/drug effects/pathology, Disease Models, Animal, Dopamine and cAMP-Regulated Phosphoprotein 32, Drug Administration Schedule, Electron Transport Complex I, Enzyme Inhibitors/administration & dosage/*toxicity, Inclusion Bodies/pathology, Infusions, Intravenous, Locus Coeruleus/drug effects/pathology, Male, Mesencephalon/drug effects/pathology, Motor Activity/drug effects, Movement Disorders/complications/etiology/*pathology, NADH, NADPH Oxidoreductases/*antagonists & inhibitors, *Nerve Tissue Proteins, Neurodegenerative Diseases/chemically induced/complications/*pathology, Neuroglia/pathology, Neurons/drug effects/metabolism/pathology, Pesticides/toxicity, Phosphoproteins/biosynthesis, Rats, Rats, Inbred Lew, Rotenone/administration & dosage/*toxicity, Serotonin/biosynthesis, Substantia Nigra/drug effects/pathology, Time, Tyrosine 3-Monooxygenase/biosynthesis.



BACK TO INDEX




Disclaimer:

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.




Last modified: Thu May 6 18:23:26 2010
Author: schwartz.


This document was translated from BibTEX by bibtex2html